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Abstract: Cancer of the head and neck is a group of upper aerodigestive tract neoplasms in which
aggressive treatments may cause harmful side effects to the patient. In the last decade, investigations
on natural compounds have been particularly successful in the field of anticancer drug research.
Our aim is to evaluate the antitumor effect of Tapirira guianensis Aubl. extracts on a panel of
head and neck squamous cell carcinoma (HNSCC) cell lines. Analysis of secondary metabolites
classes in fractions of T. guianensis was performed using Nuclear Magnetic Resonance (NMR).
Mutagenicity effect was evaluated by Ames mutagenicity assay. The cytotoxic effect, and migration
and invasion inhibition were measured. Additionally, the expression level of apoptosis-related
molecules (PARP, Caspases 3, and Fas) and MMP-2 was detected using Western blot. Heterogeneous
cytotoxicity response was observed for all fractions, which showed migration inhibition, reduced
matrix degradation, and decreased cell invasion ability. Expression levels of MMP-2 decreased
in all fractions, and particularly in the hexane fraction. Furthermore, overexpression of FAS and
caspase-3, and increase of cleaved PARP indicates possible apoptosis extrinsic pathway activation.
Antiproliferative activity of T. guianensis extract in HNSCC cells lines suggests the possibility of
developing an anticancer agent or an additive with synergic activities associated with conventional
anticancer therapy.
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1. Introduction
Cancer of the head and neck is a group of upper aerodigestive system neoplasms that corresponds
to the seventh most common cancer worldwide [1]. They are aggressive tumors and can often be
invasive and metastatic [2]. This pathology is a condition that continues to be diagnosed in an advanced
stage with low survival rate [3].
The prevalence of oral cancer in Brazil is high, especially among men in their fifth decade of
life [4]. According to INCA (Brazilian National Cancer Institute), approximately 300,000 new cases of
oral cancer were diagnosed in 2012 and it was responsible for 145,000 deaths. The five-year survival
rate of these patients is 50%–60% [4–6]. Unfortunately, even aggressive treatments, such as surgery,
radiotherapy and chemotherapy are not curative, and cause severe co-morbidities. To overcome these
limitations, the phytomedicine, which uses therapeutic agents derived from plants as an adjuvant
treatment in combination with surgery and or radiotherapy, can constitute potential options [7,8].
Some plants are known to contribute significantly within the traditional medicine of developing
countries [9,10]. In the last decade, research on natural compounds has been particularly successful in
the field of anticancer drug research. Examples of anticancer agents developed from higher plants (also
known as vascular plants) are the alkaloids vinblastine and vincristine, which were both obtained from
the Madagascar periwinkle (Catharanthus roseus) [11,12]. Brazil is home of the greatest biodiversity,
representing more than 20% of the total number of species on Earth [13]. This fact, together with
the need for developing new drugs, justifies the incentive for research programs in investigation of
potential medicinal plants.
Tapirira guianensis Aubl., a member of the Anacardiaceae family, is popularly known in Brazil as
“tatapiririca”, “cedroí” or “Pau-pombo”. It is widely distributed throughout the Brazilian territory, and
its leaves and bark are used by folk medicine to treat dermatitis, syphilis and as a cleanser, due to its
antibacterial and antifungal activity [14]. Preliminary study demonstrated that the CHCl3 extract and
two isolated compounds of the seeds of T. guianensis displayed cytotoxicity activity against human
prostate cancer [15], however the cytotoxic action of the leaves constituents remain unknown.
Studies have shown the presence of secondary compounds of the families of tannins, coumarins,
flavones, flavonols, flavanones, saponins, steroids and alkaloids in T. guianensis leaves [16,17].
The presence of hidrobenzofuranides norisoprenoids that are long chain metabolites with suggested
anti-tumor activity was also identified in the leaves [17]. Longatti et al. found that crude extract
and the hydroalcohol, chloroform and ethyl acetate fractions showed significant inhibition of matrix
metalloproteinase 2 (MMP-2) [16].
Despite these findings, the knowledge of T. guianensis anti-neoplastic activity and its molecular
mechanisms is still scarce. Therefore, in this study, we aim to evaluate the effect of this species in head
and neck tumor cell lines.
2. Results
2.1. Nuclear Magnetic Resonance (NMR) Analysis of T. guianensis
The identification by 1H NMR of secondary metabolites classes present on the crude extract and
fractions obtained by liquid–liquid extraction from T. guianensis was based on their chemical shifts
(ppm) features.
The NMR spectrum of the crude extract (C3) presented signals of chemical shifts characteristics of
alkaloids, coumarins and flavonoids in aromatic region of 6.0–7.5 ppm, hydrogen bonded to carbon
sp2 and/or neighbors heteroatoms in region of 3.4–5.3 ppm for alkaloids and coumarins and sugars
(saponin and/or glycosylated flavonoids) and hydrogen bonded to carbon sp3 in region of 0.7–2.4 ppm
for saponin and steroids. The ethyl acetate fraction (C1) showed signals of chemical shifts typical
of coumarins and flavonoids in aromatic region of 6.0–7.3 ppm, hydrogen bonded to carbon sp2
and/or neighbors heteroatoms in region of 3.0–5.8 ppm for coumarins and glycosylated flavonoids,
and hydrogen bonded to carbon sp3 in region of 0.5–1.5 ppm for steroids. The hydroalcoholic fraction
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(C2), on the other hand, exhibited signals of chemical shifts characteristics of alkaloids, coumarins
and flavonoids in aromatic region of 6.2–8.2 ppm, hydrogen bonded to carbon sp2 and/or neighbors
heteroatoms in region of 3.2–5.4 ppm for alkaloids, coumarins and sugars (saponin and/or glycosylated
flavonoids) and hydrogen bonded to carbon sp3 in region of 0.8–2.3 ppm for saponin and steroids.
Lastly, the hexane fraction (C4) displayed signals of chemical shifts typical of alkaloids in aromatic
region of 6.0–7.3 ppm and hydrogen bonded to carbon sp2 and/or neighbors heteroatoms in region of
3.0–5.8 ppm, a hydrogen bonded to carbon sp3 in region of 0.5–1.5 ppm for steroids.
2.2. Ames Mutagenicity Assay
All evaluated doses of T. guaianensis hydroalcoholic extract induced a significant increase in
revertants frequency employing the TA98 strain of Salmonella typhimurium (Table 1). The Ames test
mutagenic index (MI) values observed ranged between 3.37 (to lowest dose) and 14.84 (to highest
dose), indicating a high mutation index of this extract. However, in the TA100 strain without S9,
the mutagenicity was not observed. None of the assessed doses induced significant alterations in
revertants frequency to this strain when compared with negative control group dimethyl sulfoxide
(DMSO) and all MI values were lower than 2. Nevertheless, in studies with TA100 with metabolic
activation (+S9), the analyzed extract was mutagenic, but at a lower level, suggesting the presence of
indirect mutagens that induce base substitutions in DNA structure.
Table 1. Revertant/plate, standard deviation and mutagenicity index (MI) in the strains TA98 and
TA100 of S. typhimurium after treatment with different doses of the extract from T. guianensis, without
(−S9) and with (+S9) metabolic activation.
Treatment
TA98 TA100
−S9 +S9 −S9 +S9
Mean ± SD MI Mean ± SD MI Mean ± SD MI Mean ± SD MI
NC 16.7 ± 6.0 – 41.7 ± 5.69 – 121.7 ± 18.2 – 97.00 ± 40.85 –
Extract (µg/mL) – – – – – – – –
4.25 56.0 ± 11.0 * 3.3 140.3 ± 87.5 ** 3.4 130.0 ± 37.2 1.1 198.7 ± 24.5 * 2.0
8.67 67.3 ± 16.3 * 4.0 180.7 ± 42.2 * 4.3 118.0 ± 74.6 1.0 232.0 ± 8.9 * 2.4
16.68 136.0 ± 16.7 * 8.1 309.7 ± 74.6 * 7.4 68.7 ± 33.1 0.6 250.7 ± 35.2 * 2.6
24.09 186.0 ± 29.9 * 11.1 423.7 ± 60.5 * 10.2 110.7 ± 11.5 0.9 306.3 ± 31.2 * 3.2
30.97 246.3 ± 43.7 * 14.7 315.0 ± 10.5 * 7.6 119.7 ± 29.0 1.0 308.3 ± 41.4 * 3.2
PC 426.3 ± 40.3 * – 2839.7 ± 515.3 * – 471.0 ± 194.2 * – 1257.3 ± 159.3 * –
Mean± SD: Revertants Mean Frequency per plate± Standard Deviation; MI: Mutagenicity Index; NC: Negative
Control (DMSO − 80 µL/plate); PC: Positive Control 4-nitro-o-phenylenediamine (10 µg/plate − TA98 (−S9)),
Methylmethane sulfonate (260 µg/plate − TA100 (−S9)) or 2-Aminoanthracene (5 µg/plate − TA98 (+S9) and
TA100 (+S9)); * p < 0.05 and MI > 2; ** MI > 2.
2.3. Efficacy of T. guianensis Samples in Head and Neck Squamous Cell Carcinoma Cell Lines
The half-maximal inhibitory concentration (IC50) was determined to assess the cytotoxicity of
T. guianensis samples in head and neck tumor cell lines (Table 2) and a representation of the proliferation
and survival curves of the head and neck tumor cell lines is depicted in Figure S1. The ethyl acetate
fraction (C1) showed IC50 values between 28.0 ± 2.9 and 244.0 ± 4.8 µg/mL. The hydroalcoholic
fraction (C2) exhibited low values 14.0 ± 2.0 and 15.0 ± 2 µg/mL for SCC14 and HN13 cell lines,
respectively. The crude extract of T. guianensis (C3) display IC50 values between 45.0 ± 4.0 and
349.0 ± 5.6 µg/mL. The hexane fraction (C4) showed an IC50 values varying from 58.0 ± 1.9 to
592.0 ± 20 µg/mL. We observed that the SCC25 cell lines exhibited a resistant phenotype for all
compounds with IC50 values varying from 240 ± 26.0 to 592.0 ± 2.0 µg/mL (Table 2).
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Table 2. Classification and IC50 value response to different fractions of the T. guianensis extract in
HNSCC cell lines.
Cell Line Anatomic Site IC50 Value (Mean ± DP) mg/mL
– – C1 C2 C3 C4
SCC14 Hypopharynx 0.029 ± 0.0007 0.014 ± 0.002 0.058 ± 0.002 0.074 ± 0.002
SCC25 Oral Cavity 0.244 ± 0.048 0.240 ± 0.026 0.349 ± 0.056 0.592 ± 0.020
Fadu Hypopharynx 0.050 ± 0.002 0.023 ± 0.002 0.056 ± 0.003 0.186 ± 0.018
HN13 Tongue 0.028 ± 0.0002 0.015 ± 0.002 0.045 ± 0.004 0.058 ± 0.001
We further evaluated the growth inhibition (GI) classification and showed a moderate sensitivity
(MS) and highly sensitive (HS) for ethyl acetate (C1) and hydroalcoholic fractions (C2) in SCC14, Fadu
and HN13 cell lines, respectively (Table 3). The crude extract (C3) and hexane fraction (C4) showed
a moderate sensitivity in SCC14, Fadu and HN13 cell lines (Table 3). As expected, the SCC25 cell line
displayed a resistant (R) phenotype for all compounds (Table 3; Figure 1). Based on these results, the
most sensitive cell line (HN13) was chosen for the subsequent cellular characterization.
Table 3. Growth inhibition to different fractions of the T. guianensis extract in HSCC cell lines.
Cell Line GI Classification at 0.05 mg/mL (%)
– C1 C2 C3 C4
SCC14 MS (58.3%) HS (63.3%) MS (55.3%) MS (46.7%)
SCC25 R (25.3%) R (28%) R (25%) R (0%)
Fadu MS (47%) HS (66.3%) MS (50.3%) MS (47.3%)
HN13 MS (58.3%) HS (66.3%) MS (55.3%) MS (46.6%)
HS: highly sensitive; MS: moderate sensitive and R: resistant.
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Figure 1. Cytotoxicity profile of SCC14, SCC25, Fadu, HN13 head and neck tumor cell lines, exposed
to the different fractions of the T. guianensis extract: (A) Ethyl acetate (C1); (B) Hydroalcoholic (C2);
(C) Crude extract (C3); and (D) Hexane (C4). Bars represent the cell viability at 50 µg/mL. Bars represent
the GI score classification. Green (HS: highly sensitive); Orange (MS: moderate sensitive) and Red
(R: resistant).
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2.4. Wound Healing Migration Assay
In the HN13 cell line, we observed that after 24 h, 60.20% ± 9.35% of the control (DMSO)
wound was closed (Figure 2A,B). All fractions and extract exhibited a significant reduction of wound
closure, with the hydroalcoholic (C2) and crude extract (C3), showing the highest closure rate, namely
30.21% ± 5.81% and 19.54% ± 2.03%, respectively (p < 0.01) (Figure 2A,B).
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migration and invasion. (A) Invasion was measured at 24 h by Matrigel invasion assay, the results were
expressed in relation to the DMSO control (considered as 100% of invasion) as the mean percentage
of invasion ± SD; (B) analysis of index cell migration measured at 24 h by trans-well, the results
are expressed as the means ± SD; (C) western blot analysis using the antibodies of anti-human
M P-2. The cells lines were incubated with compounds for 24 h; (D,E) representative images (at
×40 magnification) of migration and i vasion ass ys, respectively. * p < 0. 5; ** p < 0.01.
2.6. Expression of Apo tosi Markers (PARP, Caspase 3, and Fas)
To elucidate whether crude extract and fracti s i c c ncer cell death, HN13 cells w re
treated for 24 h, and the expression of total and cleaved P RP, caspase 3, FAS and tumor necrosis
factor receptor 1 (TNFR1) proteins was evaluated by Western blot (Figure 4). All compounds showed
a significant increase of cleaved PARP compare to control (DMSO), being more significant for the crude
extract (C3) and hexane fraction (C4) (Figure 4B). Accordantly, we found increased levels of caspase 3
in HN13 cell lines treated with crude extract (C3) and hexane fraction (C4) (Figure 4C). Interestingly,
we found significant increased levels of FAS in the C3 and C4 fraction (Figure 4D), and only the C4
fraction showed increasing levels of TNFR1 (Figure 4E).
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(2000), the strai TA98 identifies ag n s able to induce g ne mutations by deletions or additions of
nuc otides on DNA structure, r sulting i frameshift m tations [19]. Besides, TA100 strain detects
compounds that cause base substitution i DNA. Con idering the e findi gs, it was ide tified that the
crude extract presents in its phytochemical consti ution agents able to induce frameshift mutations
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directly or indirectly. However, studies performed in TA100 indicated that substitution of bases was
induced by the extract only after its modification by hepatic enzymes, present in the S9 fraction.
Several studies have shown that some flavonoids can be potent mutagenic agents in different
biological systems [20,21]. In accordance with Procházková et al. (2011), the antioxidant or pro-oxidant
effects of flavonoids are related with the concentration during exposition and particular molecular
characteristics [22]. The values indicated in these tests may suggest the mechanisms of action of the
mutagenic activity evidenced in the extracts. However, the concentrations of growth inhibition of the
different cell lines do not relate with mutagenic assay.
A previous study of seeds of T. guianensis isolated two cyclic compounds which were broadly
active against a panel of human cancer cell lines [12]. Based on putative anti-tumoral effect of
T. guianensis, we tested its anti-proliferative action in a panel of four head and neck cancer cell lines
Briefly, we showed that all fractions caused a moderate (SCC14 and Fadu) or high (HN13) cytotoxicity,
with exception of the SCC25 cell line, which showed a resistant profile. We observed the classification
and response to different fractions from extract of T. guianensis in head and neck tumors cell lines
and verified that hydroalcoholic fraction showed the best results with low IC50 values (14.0 ± 2.0 and
15.0 ± 2 µg/mL). The NMR analyses showed signals of chemical shifts characteristics of alkaloids,
coumarins and flavonoids in hydroalcoholic fraction (C2). Flavonoid has been identified in crude
extract of leaves of the T. guianensis. In our study, rutin and quercetin were the flavonoids identified, the
latter present in greater quantities. These results are in agreement with previous report that detected
these components [16]. Moreover, in vitro studies have found the anticancer effects of flavonoids in
the NPC nasopharyngeal carcinoma cell line [23]; K562 leukemia cell line [24,25]; 184-B5/HER normal
breast cell line [26] and MCF-7 breast cancer cell line [27]. Furthermore, in vivo approaches indicated
that flavonoid compounds, similar to hydrobenzofuranoids obtained from T. guianensis, exhibit similar
biological activity [26,27]. Therefore, we suggest that the presence of flavonoids compounds within
the extract used in this study can be related to cytotoxic effects.
Cell motility is considered to be an important determinant of the metastatic potential of cancer
cells and can constitute promising treatment strategy [26,28]. Therefore, we used different experiments
to evaluate the effects of T. guianensis extract and fractions on the motility, migration and invasion.
We detected significant results in wound closure of the HN13 cell line exposed to all compounds.
Importantly, the hydroalcohol (C2), crude extract (C3) and hexane (C4) compounds, which showed
high levels of flavonoids such as quercetin, showed reduced invasion on the transwell migration assay.
Previous in vitro study showed that suppression of the HGF/c-Met signaling pathway by quercetin,
contributes to the anti-metastatic action and inhibit the cellular migration in melanoma cell lines [29]
and also inhibited the Wnt pathway in teratocarcinoma cell line [28].
We also showed that all compound inhibited the invasion in matrigel assay. MMPs are known
ECM-degrading enzymes and theirs activity are associated with tumor invasiveness [30] and associated
with tumorigenesis, progression and prognosis of head and neck tumor [31–33]. Herein, we observed
that hydroalcohol (C2), crude extract (C3), and hexane (C4) fractions induced MMP-2 downregulation.
These results are in line with previous work from our group that found that extracts of T. guianensis
inhibited matrix metalloproteinases [16].
Our findings suggest that several classes of secondary metabolites of C2, C3 and especially
C4 fraction may be responsible for the inhibition of cellular proliferation. Total alkaloids found in
these compounds can be related with reduced invasion. A recent study showed that total alkaloids
from Rubus alceifolius Poir inhibited the enzyme activity and reduced the expression of MMP-2 and
MMP-9 [34]. Alkaloids are secondary compounds that exhibit anti-tumor activity with broad spectrum
of action and they deserve further and deeper studies. Other studies have shown that alkaloids derived
from other plants also present antitumor activity, such as opium alkalois (papaverine, noscapine and
narceine) that induces apoptosis in cancer cell lines [35], capsaicin (an alkaloid isolated from the chili
pepper) that modulates cell cycle progression and induces apoptosis in human KB cell line (epidermoid
carcinoma) through mitochondrial membrane permeabilization and caspase activation, suggesting
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an antineoplastic activity [36]. We believe that our results offer important perspectives on cancer
targeted therapy, especially in the control of metastasis mechanisms, exhibit in vitro for C2, C3 and
C4 compounds.
Apoptosis pathway was assessed by Western blot, where we detected an overexpression of FAS,
caspase-3, TNFR1 and increased level of cleaved PARP in C3 and C4, which indicates a possible
extrinsic pathway of apoptosis. Fas-mediated apoptosis, ligands of Fas leads to strong caspase-8
activation at the DISC, thereby activating other caspases including caspase-3 in the absence of
mitochondrial involvement [37]. Despite the absence of moderate anti-neoplastic effect of the C3 and
C4 fraction, these fractions have secondary metabolites that activate an extrinsic activation mechanism
mediated by FAS and TNFR1 increased. Nevertheless, the mechanisms in which T. guianensis
participates into the complex signal pathways to achieve its anticancer role need further investigation,
such as monitoring of other proteins involved in extrinsic apoptotic signaling
4. Materials and Methods
4.1. Plant Material and Extraction
Samples of the T. guianensis were collected within the Cerrado region of Minas Gerais, Brazil
(Latitude S18◦58′08′′ and Longitude W49◦27′54′′). After identification, a voucher specimen was
registered (143407) in the Herbarium of the Department of Botany, of the Federal University of Minas
Gerais, in Belo Horizonte (Brazil).
Dried and powdered leaves (100 g) of T. guianensis were extracted by maceration (70%
hydroalcoholic solution, 15 days), which was filtered and afterwards lyophilized, resulting in 2.111 g
of crude extract. The extract was dissolved in CH3CH2OH/H2O (7:3) and successively extracted
with hexane (C6H14), chloroform (CHCl3) and ethyl acetate (C4H8O2), resulting in 1.1059 g (4677%),
0.3904 g (20.04%) and 0.2321 g (11.92%), respectively, and the hydroalcoholic residue was 0.2363 g
(12.13%) [12]. We further used the fractions: ethyl acetate (C1), hidroalcoholic (C2), crude extract (C3)
and hexane (C4).
4.2. Nuclear Magnetic Resonance (NMR) Analysis of T. guianensis
The extract and fractions from T. guianensis were prepared with deutered solvents for nuclear
magnetic resonance (NMR) analysis. The 1H NMR spectra were obtained using Bruker DRX-400MHz
spectrometer (Bruker, Billerica, MA, USA) with chloroform-d (CDCl3) and methanol-d4 (CD3OD)
using TMS as internal standard.
4.3. Ames Mutagenicity Assay
The Salmonella typhimurium mutagenicity assay was performed using the plate incorporation
protocol with the strains TA100 and TA98 of Salmonella typhimurium [38]. Five different concentrations
of the crude extract obtained from the leaves of T. guianensis were evaluated in this assay: 21.68, 16.26,
10.84, 5.42 and 2.71 mg/plate. The selection of the concentrations was based on the solubility limit of
the samples in DMSO and on their toxicity in the TA98 and TA100 [38].
Toxicity was apparent both as a reduction in the number of his + revertants and as an alteration in
the auxotrophic background (i.e., background lawn). The maximum volume of DMSO employed in
the studies was 80 µL per plate.
The various concentrations of extract tested were added to 500 µL of buffer pH 7.4, 100 µL
of bacterial culture and 2 mL of top agar. After agitation, the mixtures were poured on to plates
containing minimum agar. The plates were incubated at 37 ◦C for 48 h and the his+ revertant colonies
were manually counted. All experiments were performed in triplicate. The standard mutagens used
as positive controls in experiments were 4-nitro-o-phenylenediamine (10 µg/plate) for TA98 and
methylmethane sulfonate (260 µg/plate). DMSO (solvent) served as the negative control (80 µL/plate).
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4.4. Preparation of Standard Solutions
Each sample was accurately weighed so that 0.1 g of each could be separately re-dissolved in
1 mL of DMSO. From these solutions, serial dilutions were made to obtain lower concentrations (5, 10,
25, 50, 75, 100, and 200 µg/mL) and then, were frozen at −20 ◦C, for later use.
4.5. Cell Lines and Cell Culture
The head and neck cell lines SCC14, SCC25, Fadu and HN13 (kindly provided by Rui Manuel
Reis, Barretos Cancer Hospital) were used to determine the cytotoxic effect of different T. guianensis
extract and fractions [39]. All cell lines were initially authenticated by short tandem repeat (STR) DNA
typing according to the International Reference Standard for Authentication of Human Cell Lines
using a panel of 8 (D5S818, D13S317, D7S820, D16S539, vWA, TH01, TPOX and CSF1P0) STR loci plus
gender determination amelogenin (AMEL), using the fluorescent labeling primers as reported and
tested for mycoplasma contamination [40]. The cell lines were maintained in Dulbecco’s modified
Eagle’s medium (DMEM) (Sigma Aldrich, St. Louis, MO, USA), containing 10% fetal bovine serum
(FBS) (Gibco-Life Technologies, Grand Island, NY, USA), 1% penicillin/streptomycin (Sigma Aldrich).
Cells were incubated in a humidified atmosphere of 95% air and 5% CO2 at 37 ◦C.
4.6. Cell Viability Assay
The cell viability was assessed by MTT assay (Promega, Madison, WI, USA) as previous
described [39,41]. To determine the IC50 values, 5 × 103 cell lines/well were seeded in a 96 well
plate and incubated at increased concentrations of different extract fractions of T. guianensis, under
reduced FBS concentration (0.5%) for 72 h. The results were expressed as a percentage relatively to
control cells (DMSO treatment). The IC50 values were calculated by nonlinear regression analysis using
GraphPad Prism software (5.01 version, GraphPad Software, Inc., La Jolla, CA, USA). The growth
inhibition (GI) was detected at fixed concentration of the 50 µg/mL, and cell lines were scored as
highly sensitive (HS) with GI > 60%, moderately sensitive (MS) with GI between 40% and 60% and
resistant with GI < 40% as previously described [39,42]. All the assays were done in triplicate and
repeated at least three times.
4.7. Wound Healing Migration Assay
To assess the potential effect of T. guianensis fractions and crude extract in inhibition of cell
migration, HN13 cell line was plated in 6 well plates (2.5 × 105) in DMEM 10% FBS + 1% P/S and
allowed to adhere overnight. After reaching 95% of confluence, mono-layer cells were washed with
PBS, scraped with a plastic 200 µL pipette tip. The cell line was incubated with fixed concentrations
of each fraction in DMEM 0.5% FBS + 1% P/S. Images of the wound were captured after 0 and 24 h
by Olympus IX71 optical microscope (Olympus Optical CO. Hamburg, Germany) and the relative
migration distance was measured by the following formula:
percentage of wound closure (%) =
100× (A− B)
A
A, the width of cell wounds before incubation, and B the width of cell wounds after incubation [43].
4.8. Matrigel Invasion Assay
The invasion potential of T. guianensis fractions and crude extract was evaluated by BD BioCoat
Matrigel invasion chambers Kit (BD Biosciences, San Jose, CA, USA), following manufacturer
instructions and as previously described [44]. HN13 cell line (2.5 × 104) cells were plated in the
Matrigel-coated 24-well transwell inserts, containing DMEM (free-serum) and 2 µg/mL of the
different compounds, as a chemo-attractant was used DMEM 10% FBS. Additionally, control inserts
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(without Matrigel), were used for measuring the migratory index of HN13 cell line exposed to
different compounds.
HN13 cell line was allowed to invade and migrate for 24 h. Then, the insert membrane was fixed
with methanol iced and stained with hematoxylin/eosin. The membranes were photographed at 40×
magnification microscope and counted. The results were expressed in relation to the DMSO control
(considered as 100% of invasion) as the mean percentage of invasion ± SD.
4.9. Western Blot
To assess apoptosis and MMP-2, HN13 cell line was cultivated in 6 well plates and after 90%
plate confluence, cells were scraped in buffer lyses that contained 50 mM Tris (pH 7.6–8), 150 mM
NaCl, 5 mM EDTA, 1 mM Na3VO4, 10 mM NaF, 10 mM Na4P2O7, 1% NP-40, and protease cocktail
inhibitors. The cellular lysate was centrifuged at 13,000 rpm for 15 min in 5 ◦C and total protein of
the supernatant was quantified by Bradford method. Briefly, 20 µg of proteins from lysates were
resolved by 10% SDS-PAGE and transferred to nitrocelulose membranes in TransBlot Turbo transfer
(Bio-Rad Laboratories, Hercules, CA, USA) and incubated in 5% nonfat dried milk in TBS-T for
1 h at room temperature before primary antibody overnight incubation with PARP total/cleaved
(#9532, Cell Signaling Technology, Danvers, MA, USA), FAS (#4233, Cell Signaling Technology),
CASPASE-3 (#14220, Cell Signaling Technology), CASPASE-9 (#9505, Cell Signaling Technology),
TNFR1(#3736, Cell Signaling Technology), β-actin (#3700, Cell Signaling Technology) at 1:100 dilution,
and at 1:500 dilution for MMP-2 (sc-58386-Santa Cruz Biotechnology, Dallas, TX, USA). After washing
with TBS-T, membranes were incubated with the secondary antibody anti-rabbit (#7074, Cell Signaling
Technology) at dilution 1:5000. Immune detection was done with ECL Western Blotting Detection
Reagents in automatic ImageQuant mini LAS4000 (GE Healthcare Life Sciences, Pittsburgh, PA, USA).
Densitometric data from Western blots were performed with ImageJ software (NIH-Scion Corporation,
Bethesda, MD, USA). Caspase-3, FAS and TNFR1 values were normalized to β-actin levels and PARP
cleaved to total PARP status. All experiments were carried out in triplicate.
4.10. Statistical Analysis
For Proliferation assay the results were expressed as the means ± SD. The results for Matrigel
invasion assay were expressed in relation to the DMSO control (invaded cells) as the mean number
of cells ± SD. Single comparisons between the different conditions studied were done using
Student’s t test, and differences between groups were tested using two-way analysis of variance.
Statistical analysis was done using GraphPad Prism version 5.01 (5.01 version, GraphPad Software,
Inc.). The level of significance in all the statistical analyses was set at p ≤ 0.05. The results obtained
were evaluated employing the statistical software Salanal and adopting the Bernstein et al. (1982) [45].
The data of Ames mutagenicity assay were assessed by analysis of variance (ANOVA) followed by
a linear-regression. Furthermore, the mutagenic index (MI), which is the average number of revertants
per plate divided by the average number of revertants per plate with the negative (solvent) control,
was also calculated for each concentration. A sample was considered mutagenic when a dose–response
relationship and a two-fold increase in the number of mutants (MI ≥ 2) with at least one concentration
were observed.
5. Conclusions
The present study showed cytotoxic activity of T. guianensis extract on oral cancer cells lines, as
well as an ability to inhibit tumor migration and invasion, constituting a putative anticancer agent,
alone or in combination with classic chemotherapy and radiotherapy approaches. Nevertheless,
further studies are needed to identify the mechanisms by which T. guianensis extract acts as inhibitors
of cell proliferation.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/17/11/1839/s1.
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